Empirical Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Empirical Wealth Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$421K	Buy
2025 Q4	$257K	Buy
2025 Q3	$185K	Buy